Researchers say psilocybin, the active compound in the mushrooms, should be reclassified to treat anxiety and depression. But any such move would be years away.
from Health https://ift.tt/2QwqrfB
October 03, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Risk of Hospitalization Doubles With Delta Variant, Study FindsThe analysis of more than 40,000 coronavirus infections in England adds to evidence suggesting that Delta may cause more severe illness than other variants do. from NYT > Health https://ift.tt/3Bi9fBF … Read More
Study: Covid Creates Higher Risk for Blood Clots Than Vaccines DoThe study adds to the growing evidence that though the coronavirus vaccines are associated with certain rare side effects, those risks are dwarfed by the risks from Covid-19. from NYT > Health https://ift.tt/3Bnxf6B … Read More
At a Children’s Hospital, a Wave of Young Patients Struggling to BreatheA federal “surge team” is helping exhausted doctors and nurses through one of most trying periods in the history of Children’s Hospital New Orleans. from NYT > Health https://ift.tt/38kRHsk … Read More
Intelligence Review Yields No Firm Conclusion on Origins of VirusDeclassified portions of a report presented to President Biden revealed divisions among federal agencies over whether the virus came from a lab leak or natural processes. from NYT > Health https://ift.tt/3zqaL4j … Read More
How to Survive a Bear AttackHow much do you know about bear behavior and avoiding a bear attack? What you know — or don’t know — could determine how likely you are to survive an encounter with a testy bear. from NYT > Health https://ift.tt/3ku4gqM … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment